Volume 16, Number 4—April 2010
Dispatch
Merkel Cell Polyomavirus in Cutaneous Swabs
Vincent Foulongne
, Nicolas Kluger, Olivier Dereure, Grégoire Mercier, Jean-Pierre Molès, Bernard Guillot, and Michel Segondy
, Nicolas Kluger, Olivier Dereure, Grégoire Mercier, Jean-Pierre Molès, Bernard Guillot, and Michel Segondy
Table
Merkel cell polyomavirus DNA detection rates in swabs
| Swab type |
Patients with MCC*
(no. positive/no. tested) |
Patients with other skin diseases†
(no. positive/no. tested) |
Clinically healthy volunteers
(no. positive/no. tested) |
|---|---|---|---|
| Buccal mucosa | 1/5 | 0/13 | 1/24 |
| Cutaneous | |||
| Overall | 27/29 | 58/78 | 56/70 |
| Face | 6/6 | 14/16 | 23/25 |
| Trunk | 11/11 | 16/20 | 13/16 |
| Upper limb | 1//2 | 10/15 | 9/14 |
| Lower limb | 7/8 | 10/15 | 11/15 |
| Lesion | 2/2 | 8/12 | Not applicable |
*MCC, Merkel cell carcinoma.
†Patients with Kaposi sarcoma (n = 6), cutaneous drug side-effect (n = 3), leg ulcer (n = 3), bullous pemphigoid (n = 2), psoriasis (n = 1), and mycosis fungoides (n = 1).
Page created: December 28, 2010
Page updated: December 28, 2010
Page reviewed: December 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.